AR
Acrux Limited
ARUXF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $9.52M
P/E Ratio -
Div. Yield -
ROE 34.00%
Piotroski F-Score Weak
2/9Valuation
76 /100
Cheap P/B 6.50x
P/FCF 9.36x
P/S 2.05x
Growth
34 /100
Stable FCF growth 20.33%
Book val. growth 44.77%
Rev. growth 18.06%
Profitability
50 /100
Moderate Net margin 13.01%
Op. margin 46.06%
FCF margin 21.94%
Quality
9 /100
Poor ROE 34.00%
ROA 8.85%
Asset turnover 0.68x
Debt
28 /100
High Current ratio 1.37x
Int. coverage -7.59x
Debt/Equity 1.72x
Stability
24 /100
Unstable Rev. volatility 201.66%
EPS volatility 405.48%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ARUXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Warmbrunn
Employees
43
Headquarters
West Melbourne
Evenimente viitoare
02 MAR.
Earnings
Upcoming earnings report